Testing effectiveness (Phase 2)Study completedNCT00546078
What this trial is testing
Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America
Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 116